These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27509046)

  • 21. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.
    Gierada DS; Pinsky PF; Duan F; Garg K; Hart EM; Kazerooni EA; Nath H; Watts JR; Aberle DR
    Eur Radiol; 2017 Aug; 27(8):3249-3256. PubMed ID: 28050695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
    Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
    Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
    Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
    Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
    Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
    JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
    Kim YW; Kwon BS; Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Chung JH; Ji E; Lee CT
    Thorax; 2021 Oct; 76(10):980-988. PubMed ID: 33859050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
    Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
    J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
    Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
    Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
    Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
    Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
    Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
    Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interval lung cancers not detected on screening chest X-rays: How are they different?
    Kvale PA; Johnson CC; Tammemägi M; Marcus PM; Zylak CJ; Spizarny DL; Hocking W; Oken M; Commins J; Ragard L; Hu P; Berg C; Prorok P
    Lung Cancer; 2014 Oct; 86(1):41-6. PubMed ID: 25123333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.
    Maisonneuve P; Bagnardi V; Bellomi M; Spaggiari L; Pelosi G; Rampinelli C; Bertolotti R; Rotmensz N; Field JK; Decensi A; Veronesi G
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
    Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
    Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.
    Maldonado F; Duan F; Raghunath SM; Rajagopalan S; Karwoski RA; Garg K; Greco E; Nath H; Robb RA; Bartholmai BJ; Peikert T
    Am J Respir Crit Care Med; 2015 Sep; 192(6):737-44. PubMed ID: 26052977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
    Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
    Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.